Severe ataxia with neuropathy in hereditary gelsolin amyloidosis: A case report

References

• Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes, and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1969; 14: 314–332
   Google Scholar
• Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid 1998; 51: 55–66
   Web of Science ®Google Scholar
• Stewart H S, Parveen R, Ridgway A E, Bonshek R, Black G C. Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family. Brit J Ophthalmol 2000; 844: 390–394
   Web of Science ®Google Scholar
• Conceicao I, Sales-Luis M L, De Carvalho M, Evangelista T, Fernandes R, Paunio T, Kangas H, Coutinho P, Neves C, Saraiva M J. Gelsolin-related familial amyloidosis, Finnish type, in a Portuguese family: clinical and neurophysiological studies. Muscle Nerve 2003; 28: 715–721
   PubMed Web of Science ®Google Scholar
• Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F, Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990; 172: 1865–1867
   PubMed Web of Science ®Google Scholar
• de la Chapelle A, Tolvanen R, Boysen G, Santavy J, Bleeker-Wagemakers L, Maury C P, Kere J. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 1992; 22: 157–160
   Web of Science ®Google Scholar
• Paunio T, Kiuru S, Hongell V, Mustonen E, Syvanen A C, Bengstrom M, Palo J, Peltonen L. Solid-phase minisequencing test reveals Asp187Asn (G654A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 1992; 13: 237–239
   PubMed Web of Science ®Google Scholar
• Kwiatkowski D J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 1999; 11: 103–108
   PubMed Web of Science ®Google Scholar
• Paunio T, Kangas H, Kalkkinen N, Haltia M, Palo J, Peltonen L. Toward understanding the pathogenic mechanisms in gelsolin-related amyloidosis: in vitro expression reveals an abnormal gelsolin fragment. Hum Mol Genet 1994; 3: 2223–2229
   PubMed Web of Science ®Google Scholar
• Kangas H, Paunio T, Kalkkinen N, Jalanko A, Peltonen L. In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis. Hum Mol Genet 1996; 5: 1237–1243
   PubMed Web of Science ®Google Scholar
• Chen C D, Huff M E, Matteson J, Page L, Phillips R, Kelly J W, Balch W E. Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization. EMBO J 2001; 20: 6277–6287
   PubMed Web of Science ®Google Scholar
• Page L J, Suk J Y, Huff M E, Lim H J, Venable J, Yates J, Kelly J W, Balch W E. Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. EMBO J 2005; 24: 4124–4132
   PubMed Web of Science ®Google Scholar
• Kiuru S, Salonen O, Haltia M. Gelsolin-related spinal and cerebral amyloid angiopathy. Ann Neurol 1999; 45: 305–311
   PubMed Web of Science ®Google Scholar
• Kiuru-Enari S, Keski-Oja J, Haltia M. Cutis laxa in hereditary gelsolin amyloidosis. Brit J Dermatol 2005; 152: 250–257
   PubMed Web of Science ®Google Scholar
• Suk J Y, Zhang F, Balch W E, Linhardt R J, Kelly J W. Heparin accelerates gelsolin amyloidogenesis. Biochemistry-US 2006; 45: 2234–2242
   PubMed Web of Science ®Google Scholar
• Weeds A G, Gooch J, McLaughlin P, Maury C P. Variant plasma gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activity. FEBS Lett 1993; 335: 119–123
   PubMed Web of Science ®Google Scholar
• Robinson R C, Choe S, Burtnick L D. The disintegration of a molecule: the role of gelsolin in FAF, (familial amyloidosis Finnish type). Proc Natl Acad Sci USA 2001; 98: 2117–2118
   PubMed Web of Science ®Google Scholar
• Westberg J A, Zhang K Z, Andersson L C. Regulation of neural differentiation by normal and mutant (G654A, amyloidogenic) gelsolin. FASEB J 1999; 13: 1621–1626
   PubMed Web of Science ®Google Scholar
• Kiuru S, Javela K, Somer H, Kekomaki R. Altered platelet shape change in hereditary gelsolin Asp187Asn-related amyloidosis. Thromb Haemost 2000; 83: 491–495
   PubMed Web of Science ®Google Scholar
• Rosenberg M E, Tervo T M, Gallar J, Acosta M C, Muller L J, Moilanen J A, Tarkkanen A H, Vesaluoma M H. Corneal morphology and sensitivity in lattice dystrophy type II (familial amyloidosis, Finnish type). Invest Ophthalmol Vis Sci 2001; 42: 634–641
   PubMed Web of Science ®Google Scholar
• Kiuru-Enari S, Somer H, Seppalainen A M, Notkola I L, Haltia M. Neuromuscular pathology in hereditary gelsolin amyloidosis. J Neuropathol Exp Neurol 2002; 61: 565–571
   PubMed Web of Science ®Google Scholar
• Klaus E, Freyberger E, Kavka G, Vodicka F. Familial occurrence of a bulbar paralytic form of amyotropic lateral sclerosis with reticular corneal dystrophy and cutis hyperelastica in 3 sisters. Psychiatr Neurol (Basel) 1959; 138: 79–97
   PubMedGoogle Scholar
• Akiya S, Nishio Y, Ibi K, Uozumi H, Takahashi H, Hamada T, Onishi A, Ishiguchi H, Hoshii Y, Nakazato M. Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV. Ophthalmology 1996; 103: 1106–1110
   PubMed Web of Science ®Google Scholar
• Lauria G, Pareyson D, Grisoli M, Sghirlanzoni A. Clinical and magnetic resonance imaging findings in chronic sensory ganglionopathies. Ann Neurol 2000; 47: 104–109
   PubMed Web of Science ®Google Scholar
• Metzler J P, Fleckenstein J L, White C L, 3rd, Haller R G, Frenkel E P, Greenlee R G, Jr. MRI evaluation of amyloid myopathy. Skeletal Radiol 1992; 21: 463–465
   PubMed Web of Science ®Google Scholar
• Rintala A E, Alanko A, Makinen J, Nordstrom R, Salo H. Primary hereditary systemic amyloidosis (Meretoja's syndrome): clinical features and treatment by plastic surgery. Scand J Plast Recons 1988; 22: 141–145
   PubMed Web of Science ®Google Scholar
• Spuler S, Emslie-Smith A, Engel A G. Amyloid myopathy: an underdiagnosed entity. Ann Neurol 1998; 43: 719–728
   PubMed Web of Science ®Google Scholar
• Delcey V, Hachulla E, Michon-Pasturel U, Queyrel V, Hatron P Y, Boutry N, Lemaitre V, Vanhille P, Serratrice J, Disdier P, Juhan V, Devulder B, Thevenon A. Camptocormia: a sign of axial myopathy. Report of 7 cases. Rev Med Intern 2002; 23: 144–154
   PubMed Web of Science ®Google Scholar
• Paunio T, Kangas H, Heinonen O, Buc-Caron M H, Robert J J, Kaasinen S, Julkunen I, Mallet J, Peltonen L. Cells of the neuronal lineage play a major role in the generation of amyloid precursor fragments in gelsolin-related amyloidosis. J Biol Chem 1998; 273: 16319–16324
   PubMed Web of Science ®Google Scholar
• Makishita H, Ikeda S, Yazaki M, Yamane M, Yumoto K, Maury C J, Yanagiswa N. Postmortem pathological findings in a Japanese patient with familial amyloidosis, Finnish type (FAF). Amyloid 1996; 3: 134–139
   Web of Science ®Google Scholar
• Soto C, Castano E M, Prelli F, Kumar R A, Baumann M. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett 1995; 371: 110–114
   PubMed Web of Science ®Google Scholar
• Rostagno A, Revesz T, Lashley T, Tomidokoro Y, Magnotti L, Braendgaard H, Plant G, Bojsen-Moller M, Holton J, Frangione B, Ghiso J. Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease. J Biol Chem 2002; 277: 49782–49790
   PubMed Web of Science ®Google Scholar
• Tanskanen M, Lindsberg P J, Tienari P J, Polvikoski T, Sulkava R, Verkkoniemi A, Rastas S, Paetau A, Kiuru-Enari S. Cerebral amyloid angiopathy in a 95+ cohort: Complement activation and apolipoprotein E (APOE) genotype. Neuropathol Appl Neurobiol 2005; 31: 589–599
   PubMed Web of Science ®Google Scholar
• Nylander P O, Beckman L, Holmgren G, Steen L. Association of C3 and C4A complement types with familial amyloidotic polyneuropathy. Hum Hered 1990; 40: 272–277
   PubMed Web of Science ®Google Scholar
• Brady S T, Lasek R J, Allen R D, Yin H L, Stossel T P. Gelsolin inhibition of fast axonal transport indicates a requirement for actin microfilaments. Nature 1984; 310: 56–58
   PubMed Web of Science ®Google Scholar